$SHW 2Q15 Call – Chris, CEO: Today, we’re revising our FY15 guidance. Now expect consolidated net sales to increase 3-5% vs. FY14 & diluted EPS to be in range of $10.60-11, a 23% increase at the midpoint of the range over last year’s $8.78. By any measure 23% earnings improvement and mid-single digit sales growth is a very good year.
$FTR reorganized its business structure with the creation of new consumer and commercial business. The company said that the previous structures were more regionally focused and it had seven regions structure before the reorganization.
$PCLN believes that over the next decade China will continue to be
one of the largest opportunities for travel growth in terms of increasing market
share for the company. $PCLN also sees opportunities to increase domestic market
share in the US.
$PRGO said that in the Consumer Healthcare business, it has been seeing certain pricing pressure. Therefore, across categories $PRGO competes in, it has competitive pricing. The company expects pricing pressure to continue in different segments going forward. But given the growth in new products, $PRGO expects to overcome the pricing challenges.